Document is current
Any future updates will be listed below
-
Authors
Qu, Tongyuan
Zhang, Wenshuai
Yan, Chenhui
Ren, Danyang
Wang, Yalei
Guo, Yuhong
Guo, Qianru
Wang, Jinpeng
Liu, Liren
Han, Lei
Li, Lingmei
Huang, Qiujuan
Cao, Lu
Ye, Zhaoxiang
Zhang, Bin
Zhao, Qiang
Cao, Wenfeng http://orcid.org/0000-0001-6169-4577
-
Funding
Funding for this research was provided by:
Tianjin Municipal Bureau of Public Health (ZC20170)
Project of Tumor Translational Medicine Seed Fund of the Tianjin Medical University Cancer Institute and Hospital (1905)
National Natural Science Foundation of China (82002813, 82171932)
National Key Research and Development Program of China (2018YFC1313000, 2018YFC1313001)
- License Information
-
More Information
Article History
Received: 17 November 2022
Accepted: 16 April 2023
First Online: 22 May 2023
Declarations
:
: All in this study were approved by the Institute of Oncology, Tianjin Medical University. The study followed the 1964 Declaration of Helsinki and its later revised ethical standards. Informed consent was obtained from all participants for this study.
: All authors have agreed to publish this manuscript.
: The authors declare that they have no conflict of interest.
